Coronavirus
Antibodies Can Help Prevent Coronavirus Infections Spread in the Same Households
An antibody cocktail reduced the risk of developing symptomatic COVID-19 by 81% in people living in the same household as a positive case, according to results from a phase 3 trial.
Regeneron Pharmaceuticals monoclonal antibody cocktail is made up of two antibodies designed to block SARS-CoV-2 infection by binding to its spike protein. Under emergency use authorization, Regeneron’s antibody cocktail, as well as another one developed by the company Eli Lilly, are already being used to treat COVID-19 patients who aren’t hospitalized but are at high risk for developing severe disease, according to The New York Times.
